IFM Therapeutics

Novartis hits the cGAS, taking option to buy IFM unit for $90M upfront
Fierce Biotech
Wed, 03/13/24 - 10:40 am
Novartis
cGAS
IFM Therapeutics
Numero quattro: Immunology experts at deal-focused IFM line up $55.5M for the next leg of their drug exploration journey
Endpoints
Mon, 12/2/19 - 09:47 am
IFM Therapeutics
immunology
Atlas Ventures
With third pharma deal, IFM's unorthodox approach paying off
Biopharma Dive
Thu, 09/5/19 - 08:22 pm
IFM Therapeutics
Novartis
Bristol-Myers Squibb
Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike
Xconomy
Thu, 07/19/18 - 09:54 am
IFM Therapeutics
Bristol-Myers Squibb
IFM Tre
Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal
Endpoints
Thu, 08/3/17 - 06:22 pm
Bristol-Myers Squibb
IFM Therapeutics
oncology
M&A